Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: Point-of-care (POC) devices could be used to measure hemoglobin A 1c (HbA 1c ) in the doctors’ office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical performance of some of these devices. We carried out a systematic review and meta-analysis using a novel approach to compare the accuracy and precision of POC HbA 1c devices. Methods: Medline, Embase and Web of Science databases were searched in June 2015 for published reports comparing POC HbA 1c devices with laboratory methods. Two reviewers screened articles and extracted data on bias, precision and diagnostic accuracy. Mean bias and variability between the POC and laboratory test were combined in a meta-analysis. Study quality was assessed using the QUADAS2 tool. Results: Two researchers independently reviewed 1739 records for eligibility. Sixty-one studies were included in the meta-analysis of mean bias. Devices evaluated were A1cgear, A1cNow, Afinion, B-analyst, Clover, Cobas b101, DCA 2000/Vantage, HemoCue, Innovastar, Nycocard, Quo-Lab, Quo-Test and SDA1cCare. Nine devices had a negative mean bias which was significant for three devices. There was substantial variability in bias within devices. There was no difference in bias between clinical or laboratory operators in two devices. Conclusions: This is the first meta-analysis to directly compare performance of POC HbA 1c devices. Use of a device with a mean negative bias compared to a laboratory method may lead to higher levels of glycemia and a lower risk of hypoglycaemia. The implications of this on clinical decision-making and patient outcomes now need to be tested in a randomized trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, deviations near key clinical thresholds, such as 6.5% for diagnosis or 7.0-8.0% for treatment decisions, may result in misclassification and inappropriate therapeutic interventions (9,10).”
From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous reviews have emphasized that such variability remains a persistent challenge in standardizing HbA1c measurement across platforms and settings (10,35).”
From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A meta-analysis published in 2017 revealed continuing problems with the accuracy of POCT devices (324).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [324]
The cited source says what the claim attributes to it.
In the citing paper
“Analysis of 60 studies with 13 devices showed that most devices had negative bias (all the others had positive bias) and large standard deviations.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [324]
The cited source says what the claim attributes to it.
In the citing paper
“For example, a prior meta-analysis reported substantial variability in bias across different POC platforms, with some devices showing deviations beyond clinically acceptable limits (10).”
From Comparison of point‑of‑care HbA1c devices with laboratory HPLC methods: A systematic review and meta‑analysis (2026) · cites this paper as [10]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 2×
“The long-term effects of this are not known, but studies have shown that even small increases in HbA1c increase the risk of micro- and macrovascular complications [1].”
BackgroundInterpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression
Harbord, R. M., & Whiting, P. (2009) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0900900203 · Cited by 453 · cited 3×
“All analyses were carried out using Stata 12.0SE (StataCorp, College Station, TX, USA).”
MethodInfluentialCagliero, E., Levina, E. V., & Nathan, D. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1785 · Cited by 246
Lenters-Westra, E., & Slingerland, R. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.130641 · Cited by 228 · cited 3×
“The suitability of many of these devices for the accurate measurement of HbA1c has been questioned, with some POC HbA1c test devices reported not to meet accepted accuracy and precision criteria [3].”
BackgroundMethod
Research works printed but not linked: 10
- Wood JA, Kaminski BM, Kollman C, Diabetes P. The accuracy and precision of the axis-shield afinion HbA1c measure ment device. Diabetes 2011; Conference: 71st Scientific Sessions of the American Diabetes Association San Diego, CA United States. Conference Start: 20110624 Conference End: 20110628. Conference Publication: (var.pagings). 60:A237.
- Health Quality Ontario. Point-of-care hemoglobin A1c testing: an evidence-based analysis. Ont Health Technol Assess Ser 2014;14:1–30.
- Clark AL, Irvin BR, Isbell AW, Ammirati EA. Multi-site correlation of A1cNow %A1C assay to a standardized laboratory. Clin Chem 2005;51:A259–A.
- Estevez Fidalgo P, Pineiro Caamano A, Otero Santiago M, Garcia Aschauer JM, Lorenzo Freire MT, Espana Barrada R, et al. Validation of HbA1c results obtained with a point of care instrument. Clin Chem Lab Med 2014;52:S1523.
- Harris S, Tokmakejian S, Edmonds M, Webster-Bogaert S, Mahon J, Porter S, et al. Validation of the bayer DCA2000 (TM) as a point-of-care measure of glycosylated haemoglobin. Diabetes 2000;49:A110–A.
- Heng PY, Fun S, Chui KL, Taufik MA, Lew MY, Wong MS. An evaluation of the performance of Roche Cobas b101 point-of-care system in the measurement of haemoglobin A1C. Clin Chem Lab Med 2015;53:S623.
- Jou JM, Bedini JL, Seuma J, Luna N, Kinder M. Evaluati on of the point of care a1cnow+ analy zer for HBA1C. International Journal of Laboratory Hematology 2013; Conference: 26th International Symposium on Technological Innovations in Laboratory Hematology, ISLH 2013 Toronto, ON Canada. Conference Start: 20130510 Conference End: 20130512. Conference Publication: (var.pagings). 35:50.
- Rossi L, Della Bartola L, Giampietro O, Consani C, Pellegrini G, Matteucci E. Point-of-care hbA1c testing in a clinical setting: performance analysis. Clin Chem Lab Med 2015;53:S543.
- Thueringer JT, Ishani A, Rector T, Greer N, Ercan-Fang N. Comparison of a1c measurements from a home test device to a hospital laboratory. Diabetes 2012; Conference: 72nd Scientific Sessions of the American Diabetes Association Philadelphia, PA, United States. Conference Start: 20120608 Conference End: 20120612. Conference Publication: (var.pagings). 61:A218.
- Williams PF, Tan K, Sherfan J, Woolnough C, Lin E, Brown M, et al. Comparison of three point of care (POC) HbA1c devices with cation exchange and capillary electrophoresis. Diabetes 2014;63:A220.
Cited by
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Early Outcomes From the English National Health Service Diabetes Prevention Programme
Valabhji, J., Barron, E., Bradley, D., Bakhai, C., Fagg, J., O’Neill, S., Young, B., Wareham, N., Khunti, K., Jebb, S., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1425 · Cited by 211
Metadata
- Authors
- Hirst, J. A., McLellan, J. H., Price, C. P., English, E., Feakins, B. G., Stevens, R. J., & Farmer, A. J.
- Affiliations
- University of Oxford (GB)
- University of East Anglia (GB)
- University of Oxford, Nuffield Department of Primary Care Health Sciences, United Kingdom of Great Britain and Northern Ireland
- Corresponding author
- Hirst, Jennifer A.
- ORCID
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2016-09-22
- Volume
- 55
- Issue
- 2
- Pages
- 167-180
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W2522836126
- Semantic Scholar
- 8e548171bfc62f7596eb09a74b5c3e65a37fe32d
- Cited by
- 102
- References
- 68
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 7 · 2023: 11 · 2022: 17 · 2021: 15 · 2020: 7 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 2
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Funders
- National Institute for Health and Care Research (DRF-2013-06-086, NF-SI-0512-10077)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- point-of-care testing, HbA1c, device accuracy, measurement bias, precision, diabetes management, hypoglycemia risk, HemoCue
- MeSH terms
- Glycated Hemoglobin, Humans, Practice Guidelines as Topic, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1515/cclm-2016-0303
- The paper
- Hirst, J. A., McLellan, J. H., Price, C. P., English, E., Feakins, B. G., Stevens, R. J., & Farmer, A. J. (2017). Performance of point-of-care HbA 1c test devices: implications for use in clinical practice – a systematic review and meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2016-0303
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.